Differential Peripheral Proteomic Biosignature of Fluoxetine Response in a Mouse Model of Anxiety/Depression

The incorporation of peripheral biomarkers in the treatment of major depressive disorders (MDD) could improve the efficiency of treatments and increase remission rate. Peripheral blood mononuclear cells (PBMCs) represent an attractive biological substrate allowing the identification of a drug respon...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Cell Neurosci
Auteurs principaux: Mendez-David, Indira, Boursier, Céline, Domergue, Valérie, Colle, Romain, Falissard, Bruno, Corruble, Emmanuelle, Gardier, Alain M., Guilloux, Jean-Philippe, David, Denis J.
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2017
Sujets:
Neuroscience
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5561647/
https://ncbi.nlm.nih.gov/pubmed/28860968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fncel.2017.00237
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires